1. Public Health Service Task Force: Recommendations for use of antiretroviral drugs in pregnant HIV-infected women for maternal health and interventions to reduce perinatal HIV transmission in the United States. http://AIDSinfo.nih.gov . Accessed July 8, 2008.
2. Public Health Service Task Force: Recommendations for use of antiretroviral drugs in pregnant HIV-infected women for maternal health and interventions to reduce perinatal HIV transmission in the United States. Supplement: Safety and toxicity of individual antiretroviral agents in pregnancy. http://AIDSinfo.nih.gov . Accessed November 2, 2007.
3. Antiretroviral Pregnancy Registry Steering Committee: Antiretroviral Pregnancy Registry international interim report for 1 January 1989 through 31 July 2008. http://www.APRegistry.com . Accessed February 28, 2009.
4. European Collaborative Study. Exposure to antiretroviral therapy in utero or early life: the health of uninfected children born to HIV-infected women. J Acquir Immune Defic Syndr 2003, 32:380–387.
5. Thorne C, Patel D, Newell ML, European Collaborative Study: Increased risk of adverse pregnancy outcomes in HIV-infected women treated with highly active antiretroviral therapy in Europe. AIDS 2004, 18:2337–2339.